All Stories

  1. Epigenetic remodeling in insect immune memory
  2. Aktuell
  3. A Robust One-Step Recombineering System for Enterohemorrhagic Escherichia coli
  4. Role of aggregate-forming pilus (AFP) in adherence and colonization of both intestinal and urinary tracts
  5. The emerging role of epigenetic mechanisms in insect defense against pathogens
  6. The aggregate-forming pili (AFP) mediates the aggregative adherence of a hybrid-pathogenic Escherichia coli (UPEC/EAEC) isolated from a urinary tract infection
  7. Collateral effects of deletion of nlpD on rpoS and rpoS-dependent genes. Reply.
  8. Compared with Cotrimoxazole Nitroxoline Seems to Be a Better Option for the Treatment and Prophylaxis of Urinary Tract Infections Caused by Multidrug-Resistant Uropathogens: An In Vitro Study
  9. Insights into evolution and coexistence of the colibactin- and yersiniabactin secondary metabolite determinants in enterobacterial populations
  10. The Superior Adherence Phenotype of E. coli O104:H4 is Directly Mediated by the Aggregative Adherence Fimbriae Type I
  11. Metabolomics Study on Pathogenic and Non-pathogenic E. coli with Closely Related Genomes with a Focus on Yersiniabactin and Its Known and Novel Derivatives
  12. Genome Sequence of the Fish Brain Bacterium Clostridium tarantellae
  13. Molecular Analyses of Over Hundred Sixty Clinical Isolates of SARS-CoV-2: Insights on Likely Origin, Evolution and Spread, and Possible Intervention
  14. Transcriptional and Translational Inhibitors Block SOS Response and Shiga Toxin Expression in Enterohemorrhagic Escherichia coli
  15. Origin and Evolution of Hybrid Shiga Toxin-Producing and Uropathogenic Escherichia coli Strains of Sequence Type 141
  16. Phenotypic and Genotypic Characterization of Escherichia coli Causing Urinary Tract Infections in Kidney-Transplanted Patients
  17. Fimbriae reprogram host gene expression – Divergent effects of P and type 1 fimbriae
  18. Effect of chlorine on cultivability of Shiga toxin producing Escherichia coli (STEC) and β-lactamase genes carrying E. coli and Pseudomonas aeruginosa
  19. Core elements of the vegetative replication control of the Inc1 plasmid pO104_90 of Escherichia coli O104:H4 also regulate its transfer frequency
  20. Antiadhesive hydroalcoholic extract from Apium graveolens fruits prevents bladder and kidney infection against uropathogenic E . coli
  21. Pathophysiology of Escherichia coli pneumonia: Respective contribution of pathogenicity islands to virulence
  22. Characterization of Asymptomatic Bacteriuria Escherichia coli Isolates in Search of Alternative Strains for Efficient Bacterial Interference against Uropathogens
  23. Whole-Genome Draft Sequences of Nine Asymptomatic Escherichia coli Bacteriuria Isolates from Diabetic Patients
  24. Breaching the wall: morphological control of efficacy of phthalocyanine-based photoantimicrobials
  25. Male kidney allograft recipients at risk for urinary tract infection?
  26. Striking an access to the bacteria via (reversible) control of lipophilicity
  27. High Throughput Sequencing for Detection of Foodborne Pathogens
  28. Boronic Acid Functionalized Photosensitizers: A Strategy To Target the Surface of Bacteria and Implement Active Agents in Polymer Coatings
  29. Boronic Acid Functionalized Photosensitizers: A Strategy to Target the Surface of Bacteria and Implement Active Agents in Polymer Coatings
  30. Infection with uropathogenic E. coli induces dynamic epigenetic reprogramming of innate immunity
  31. No evidence for a bovine mastitis Escherichia coli pathotype
  32. Aqueous extract from Orthosiphon stamineus leaves prevents bladder and kidney infection in mice
  33. Zinc treatment is efficient against Escherichia coli α-haemolysin-induced intestinal leakage in mice
  34. The Food Contaminant Deoxynivalenol Exacerbates the Genotoxicity of Gut Microbiota
  35. Host cell interactions of outer membrane vesicle-associated virulence factors of enterohemorrhagic Escherichia coli O157: Intracellular delivery, trafficking and mechanisms of cell injury
  36. Making and Breaking Barriers to Overcome Microbial Infections
  37. No evidence for a bovine mastitis Escherichia coli pathotype
  38. The primary transcriptome of the Escherichia coli O104:H4 pAA plasmid and novel insights into its virulence gene expression and regulation
  39. Long-term survival of the Shiga toxin-producing Escherichia coli O104:H4 outbreak strain on fenugreek seeds
  40. Combined Analysis of Variation in Core, Accessory and Regulatory Genome Regions Provides a Super-Resolution View into the Evolution of Bacterial Populations
  41. Iron Homeostasis Regulates the Genotoxicity of Escherichia coli That Produces Colibactin
  42. Genes on a Wire: The Nucleoid-Associated Protein HU Insulates Transcription Units in Escherichia coli
  43. Whole-Genome Draft Sequences of Six Commensal Fecal and Six Mastitis-Associated Escherichia coli Strains of Bovine Origin: TABLE 1
  44. Bacterial Suppression of RNA Polymerase II-Dependent Host Gene Expression
  45. Uropathogenic E. coli Exploit CEA to Promote Colonization of the Urogenital Tract Mucosa
  46. Escherichia coli: an old friend with new tidings
  47. Asymtomatic Bacteriuria as a Model to Study the Coevolution of Hosts and Bacteria
  48. Genome Plasticity, Bacterial
  49. Primary Amine Oxidase of Escherichia coli Is a Metabolic Enzyme that Can Use a Human Leukocyte Molecule as a Substrate
  50. In Vivo Consumption of Cranberry Exerts ex Vivo Antiadhesive Activity against FimH-Dominated Uropathogenic Escherichia coli: A Combined in Vivo, ex Vivo, and in Vitro Study of an Extract from Vaccinium macrocarpon
  51. Virulence from vesicles: Novel mechanisms of host cell injury by Escherichia coli O104:H4 outbreak strain
  52. Das bililäre Mikrobiom bei hepatobiliären Erkrankungen
  53. 10.1016/j.tube.2014.12.007
  54. Sa1328 Analysis of the Human Biliary Microbiome and Its Alterations in Biliary Tract Diseases
  55. Complete Genome Sequences of Escherichia coli Strains 1303 and ECC-1470 Isolated from Bovine Mastitis
  56. Genomic Avenue to Avian Colisepticemia
  57. Mobile genetic elements and pathogenicity islands encoding bacterial toxins
  58. List of Contributors
  59. Characterization of Urinary Tract Infection-Associated Shiga Toxin-Producing Escherichia coli
  60. Fur Is the Master Regulator of the Extraintestinal Pathogenic Escherichia coli Response to Serum
  61. Prevalence of autotransporters in Escherichia coli: what is the impact of phylogeny and pathotype?
  62. Prevalence and persistence of Escherichia coli in the airways of cystic fibrosis patients—An unrecognized CF pathogen?
  63. The Contribution of Pathogenicity Islands to the Evolution of Bacterial Pathogens
  64. Impact of Genome Plasticity on Adaptation of Escherichia coli during Urinary Bladder Colonization
  65. α-Haemolysin ofEscherichia coliin IBD: a potentiator of inflammatory activity in the colon
  66. Rare Emergence of Symptoms during Long-Term Asymptomatic Escherichia coli 83972 Carriage without an Altered Virulence Factor Repertoire
  67. Heteropathogenic virulence and phylogeny reveal phased pathogenic metamorphosis inEscherichia coliO2:H6
  68. Characterization of Escherichia coli Isolates from Hospital Inpatients or Outpatients with Urinary Tract Infection
  69. The Carbon Storage Regulator (Csr) System Exerts a Nutrient-Specific Control over Central Metabolism in Escherichia coli Strain Nissle 1917
  70. Sequence Variability of P2-Like Prophage Genomes Carrying the Cytolethal Distending Toxin V Operon in Escherichia coli O157
  71. Bacterial control of host gene expression through RNA polymerase II
  72. The long polar fimbriae operon and its flanking regions in bovine Escherichia coli O157:H43 and STEC O136:H12 strains
  73. Phylogenetic group-associated differences in regulation of the common colonization factor Mat fimbria inEscherichia coli
  74. E. coli as an All-Rounder: The Thin Line Between Commensalism and Pathogenicity
  75. Between Pathogenicity and Commensalism
  76. E. coli as an All-Rounder: The Thin Line Between Commensalism and Pathogenicity
  77. Between Pathogenicity and Commensalism
  78. Evolution und Infektionsbiologie der mit dem hämolytisch-urämischen Syndrom (HUS) assoziierten E.  coli (HUSEC)
  79. Genotoxicity of Escherichia coli Nissle 1917 strain cannot be dissociated from its probiotic activity
  80. Genetic and phylogenetic analysis of avian extraintestinal and intestinalEscherichia coli
  81. The enemy within us: lessons from the 2011 European Escherichia coli O104:H4 outbreak
  82. Genome Plasticity and Infectious Diseases
  83. The fimbriae activator MatA switches off motility in Escherichia coli by repression of the flagellar master operon flhDC
  84. Gut inflammation can boost horizontal gene transfer between pathogenic and commensal Enterobacteriaceae
  85. Climate change and infectious diseases – Impact of global warming and climate change on infectious diseases: Myth or reality?
  86. Variation in endogenous oxidative stress in Escherichia coli natural isolates during growth in urine
  87. What defines extraintestinal pathogenic Escherichia coli?
  88. 9th International Meeting on Microbial Epidemiological Markers
  89. Comparison of Asymptomatic Bacteriuria Escherichia coli Isolates from Healthy Individuals versus Those from Hospital Patients Shows that Long-Term Bladder Colonization Selects for Attenuated Virulence Phenotypes
  90. Acute Escherichia coli Prostatitis in Previously Health Young Men: Bacterial Virulence Factors, Antimicrobial Resistance, and Clinical Outcomes
  91. The lipopolysaccharide of the mastitis isolate Escherichia coli strain 1303 comprises a novel O-antigen and the rare K-12 core type
  92. Chromosomal instability in enterohaemorrhagic Escherichia coli O157:H7: impact on adherence, tellurite resistance and colony phenotype
  93. Mobilisation and remobilisation of a large archetypal pathogenicity island of uropathogenic Escherichia coli in vitro support the role of conjugation for horizontal transfer of genomic islands
  94. Pathogen Specific, IRF3-Dependent Signaling and Innate Resistance to Human Kidney Infection
  95. Pathogenomic comparison of human extraintestinal and avian pathogenic Escherichia coli – Search for factors involved in host specificity or zoonotic potential
  96. Host Imprints on Bacterial Genomes—Rapid, Divergent Evolution in Individual Patients
  97. Editorial
  98. Bacterial genome plasticity and its impact on adaptation during persistent infection
  99. Mat fimbriae promote biofilm formation by meningitis-associated Escherichia coli
  100. Genome dynamics and its impact on evolution of Escherichia coli
  101. Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coli
  102. Differential effects and interactions of endogenous and horizontally acquired H‐NS‐like proteins in pathogenic Escherichia coli
  103. Safety of Probiotic Escherichia coli Strain Nissle 1917 Depends on Intestinal Microbiota and Adaptive Immunity of the Host
  104. Virulenzfaktoren uropathogener Erreger
  105. Differential effects and interactions of endogenous and horizontally acquired H-NS-like proteins in pathogenicEscherichia coli
  106. High-throughput microarray technology in diagnostics of enterobacteria based on genome-wide probe selection and regression analysis
  107. Cell Wall Structure and Pathogenicity
  108. O-acetyltransferase geneneuOis segregated according to phylogenetic background and contributes to environmental desiccation resistance inEscherichia coliK1
  109. Vacuolisation of human microvascular endothelial cells by enterohaemorrhagic Escherichia coli
  110. Genetic Structure and Distribution of the Colibactin Genomic Island among Members of the Family Enterobacteriaceae
  111. Impact of O-glycosylation on the molecular and cellular adhesion properties of the Escherichia coli autotransporter protein Ag43
  112. Analysis of the sfaXII locus in the Escherichia coli meningitis isolate IHE3034 reveals two novel regulatory genes within the promoter-distal region of the main S fimbrial operon
  113. Adaptation of Pathogenic E. coli to Various Niches: Genome Flexibility is the Key
  114. “Gently Rough”: The Vaccine Potential of aSalmonella entericaRegulatory Lipopolysaccharide Mutant
  115. Cytolethal Distending Toxin Type I and Type IV Genes Are Framed with Lambdoid Prophage Genes in Extraintestinal Pathogenic Escherichia coli
  116. Targeting virulence traits: potential strategies to combat extraintestinal pathogenic E. coli infections
  117. Genotyping DNA chip for the simultaneous assessment of antibiotic resistance and pathogenic potential of extraintestinal pathogenic Escherichia coli
  118. Pathogenomics: An updated European Research Agenda
  119. Genomic fluidity and pathogenic bacteria: applications in diagnostics, epidemiology and intervention
  120. Characterisation of Escherichia coli strains involved in transcytosis across gut epithelial cells exposed to metabolic and inflammatory stress
  121. Delineation of the recombination sites necessary for integration of pathogenicity islands II and III into the Escherichia coli 536 chromosome
  122. Die Biofilm-Bildung und ihre Bedeutung bei Harnwegsinfektionen
  123. Molecular Basis of Commensalism in the Urinary Tract: Low Virulence or Virulence Attenuation?
  124. Aspects of genome plasticity in pathogenic Escherichia coli
  125. Expression analysis of the colibactin gene cluster coding for a novel polyketide in Escherichia coli
  126. Escherichia�coli ?-haemolysin induces focal leaks in colonic epithelium: a novel mechanism of bacterial translocation
  127. tDNA locus polymorphism and ecto-chromosomal DNA insertion hot-spots are related to the phylogenetic group of Escherichia coli strains
  128. Down-Regulation of Key Virulence Factors Makes the Salmonella enterica Serovar Typhimurium rfaH Mutant a Promising Live-Attenuated Vaccine Candidate
  129. Tumor Necrosis Factor Alpha- and Inducible Nitric Oxide Synthase-Producing Dendritic Cells Are Rapidly Recruited to the Bladder in Urinary Tract Infection but Are Dispensable for Bacterial Clearance
  130. How to become a uropathogen: Comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains
  131. Escherichia coli Induces DNA Double-Strand Breaks in Eukaryotic Cells
  132. Role of Histone-Like Proteins H-NS and StpA in Expression of Virulence Determinants of Uropathogenic Escherichia coli
  133. Role of pathogenicity island-associated integrases in the genome plasticity of uropathogenic Escherichia coli strain 536
  134. Both α-haemolysin determinants contribute to full virulence of uropathogenic Escherichia coli strain 536
  135. Pathogenomics of Escherichia coli and Shigella Species
  136. Active Cytotoxic Necrotizing Factor 1 Associated with Outer Membrane Vesicles from Uropathogenic Escherichia coli
  137. Demonstration of regulatory cross-talk between P fimbriae and type 1 fimbriae in uropathogenic Escherichia coli
  138. Glycosylation of the Self-Recognizing Escherichia coli Ag43 Autotransporter Protein
  139. The Transcriptional Antiterminator RfaH Represses Biofilm Formation in Escherichia coli
  140. Pathogenomics
  141. Mobile genetic elements and pathogenicity islands encoding bacterial toxins
  142. (Patho-)Genomics of Escherichia coli
  143. Regulation of type 1 fimbriae synthesis and biofilm formation by the transcriptional regulator LrhA of Escherichia coli
  144. Presence and Characterization of a Mosaic Genomic Island Which Distinguishes Sorbitol-Fermenting Enterohemorrhagic Escherichia coli O157:H− from E. coli O157:H7
  145. Transcriptional regulation through RfaH contributes to intestinal colonization by Escherichia coli
  146. Characterization of the flexible genome complement of the commensal Escherichia coli strain A0 34/86 (O83 : K24 : H31)
  147. Novel multivalent mannose compounds and their inhibition of the adhesion of type 1 fimbriated uropathogenic E. coli
  148. The Pathogenicity Island-Associated K15 Capsule Determinant Exhibits a Novel Genetic Structure and Correlates with Virulence in Uropathogenic Escherichia coli Strain 536
  149. Analysis of the Genome Structure of the Nonpathogenic Probiotic Escherichia coli Strain Nissle 1917
  150. Oral Immunization with an rfaH Mutant Elicits Protection against Salmonellosis in Mice
  151. Instability of Pathogenicity Islands in Uropathogenic Escherichia coli 536
  152. Excision of the high-pathogenicity island of Yersinia pseudotuberculosis requires the combined actions of its cognate integrase and Hef, a new recombination directionality factor
  153. Genomic islands in pathogenic and environmental microorganisms
  154. Pathogenicity Islands and Their Role in Bacterial Virulence and Survival
  155. Pathogenomics of mobile genetic elements of toxigenic bacteria
  156. The Molecular Basis of Infectious Diseases: Pathogenicity Islands and Other Mobile Genetic Elements
  157. Prokaryotic Chromosomes and Disease
  158. Bacteroides vulgatus protects against escherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice
  159. Cytolethal Distending Toxin Gene Cluster in Enterohemorrhagic Escherichiacoli O157:H− and O157:H7: Characterization and Evolutionary Considerations
  160. Commensal bacteria make a difference
  161. Analysis of Genome Plasticity in Pathogenic and Commensal Escherichia coli Isolates by Use of DNA Arrays
  162. A Single Nucleotide Exchange in the wzy Gene Is Responsible for the Semirough O6 Lipopolysaccharide Phenotype and Serum Sensitivity of Escherichia coli Strain Nissle 1917
  163. Genetic Structure and Distribution of Four Pathogenicity Islands (PAI I536 to PAI IV536) of Uropathogenic Escherichia coli Strain 536
  164. Loss of Regulatory Protein RfaH Attenuates Virulence of Uropathogenic Escherichia coli
  165. Pathogenicity islands of uropathogenic E. coli and the evolution of virulence
  166. Efficient expression of the α-haemolysin determinant in the uropathogenic Escherichia coli strain 536 requires the leuX -encoded tRNA 5 Leu
  167. Virulence factors of uropathogens
  168. Identification and distribution of the enterohemorrhagic Escherichia coli factor for adherence (efa1) gene in sorbitol- fermenting Escherichia coli O157 : H−
  169. Genome Plasticity in Pathogenic and Nonpathogenic Enterobacteria
  170. Genome Plasticity in Pathogenic and Nonpathogenic Enterobacteria
  171. EVOLUTION OF MICROBIAL PATHOGENS
  172. Identification and Characterization of a Novel Genomic Island Integrated at selC in Locus of Enterocyte Effacement-Negative, Shiga Toxin-Producing Escherichia coli
  173. Whole genome plasticity in pathogenic bacteria
  174. S-Fimbria-Encoding Determinant sfaI Is Located on Pathogenicity Island III536 of UropathogenicEscherichia coli Strain 536
  175. Regulation of the tRNA 5 Leu -encoding gene leuX that is associated with a pathogenicity island in the uropathogenic Escherichia coli strain 536
  176. A subtractive hybridisation analysis of genomic differences between the uropathogenic E. coli strain 536 and the E. coli K-12 strain MG1655
  177. Expression of Hemin Receptor Molecule ChuA Is Influenced by RfaH in Uropathogenic Escherichia coliStrain 536
  178. The Pathogenicity Islands (PAIs) of the Uropathogenic Escherichia coli Strain 536: Island Probing of PAI II 536
  179. Pathogenicity islands and phage conversion: evolutionary aspects of bacterial pathogenesis
  180. Toxin genes on pathogenicity islands: impact for microbial evolution
  181. Evolution of microbial pathogens
  182. Influence of pathogenicity islands and the minor leuX-encoded tRNA5Leu on the proteome pattern of the uropathogenic Escherichia coli strain 536
  183. The leuX -encoded tRNA 5 Leu but not the pathogenicity islands I and II influence the survival of the uropathogenic Escherichia coli strain 536 in CD-1 mouse bladder mucus in the stationary phase
  184. The leuX-encoded tRNA5Leu but not the pathogenicity islands I and II influence the survival of the uropathogenic Escherichia coli strain 536 in CD-1 mouse bladder mucus in the stationary phase
  185. The Pai‐associated leuX specific tRNA Leu 5 affects type 1 fimbriation in pathogenic Escherichia coli by control of FimB recombinase expression
  186. Purification and characterization of a membrane-bound hydrogenase from Sporomusa sphaeroides involved in energy-transducing electron transport
  187. How Bacterial Pathogens were Constructed
  188. Analysis of Pathogenicity Islands of STEC
  189. Pathogenomics: Identification of Novel Drug Targets and Vaccine Candidates in Bacteria
  190. Pathogenicity Islands of Uropathogence E. Coli and Evolution of Virulence
  191. Analysis of the Hemolysin Determinants of the Uropathogenic Escherichia coli Strain 536